AtriCure, Inc.
-
Ticker
ATRC
-
Industry
Medical Instruments & Supplies More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Mason, Ohio
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical
…More device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide.
REPORT RATINGS
4.8 / 5.0 (75)
AtriCure, Inc. reports have an aggregate usefulness score of 4.8 based on 75 reviews.
AtriCure, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 ESG Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived AtriCure, Inc. Sustainability Report, AtriCure, Inc. Corporate Social Responsibility Report, AtriCure, Inc. CSR Report, AtriCure, Inc. Corporate Responsibility, AtriCure, Inc. CR Report, AtriCure, Inc. Citizenship Report, AtriCure, Inc. ESG Report, and AtriCure, Inc. Environmental Report online.